Atrazine Inhalation Worsen Pulmonary Fibrosis Regulating the Nuclear Factor-Erythroid 2-Related Factor (Nrf2)

Ramona D'Amico1, Francesco Monaco2, Roberta Fusco1

  • 1Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.

Abstract

Insights

Atrazine (ATR) exposure worsens lung fibrosis and oxidative stress, particularly when combined with bleomycin. This herbicide also impairs motor function and decreases protective Nrf2 pathways in the lungs and brain.

Area of Science:

  • Environmental toxicology
  • Pulmonary medicine
  • Neuroscience

Background:

  • Pulmonary fibrosis stems from oxidative stress, common in genetic, autoimmune, or environmental causes.
  • Atrazine (ATR), a widely used herbicide, and bleomycin, a chemotherapy drug, induce oxidative stress.
  • The impact of ATR on pulmonary fibrosis remains uninvestigated.

Purpose of the Study:

  • To investigate the effects of Atrazine (ATR) exposure on pulmonary fibrosis.
  • To determine if ATR exacerbates bleomycin-induced lung injury.
  • To assess the impact of ATR on oxidative stress and Nrf2 pathways.

Main Methods:

  • Mice were exposed to ATR, bleomycin, or both.
  • Lung and blood samples were collected for analysis.
  • Behavioral tests (open field, rotarod) assessed motor function.

Main Results:

  • ATR and bleomycin significantly increased lung damage, fibrosis, and oxidative stress.
  • Combined ATR and bleomycin exposure worsened lung pathology.
  • ATR exposure led to significant motor and non-motor impairments.

Conclusions:

  • ATR exposure exacerbates pulmonary fibrosis and oxidative stress.
  • ATR negatively impacts neurological function.
  • ATR exposure downregulates the protective Nrf2 pathway in the lungs and brain.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
815
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
670
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
682
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
232